BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

785 related articles for article (PubMed ID: 16766648)

  • 1. Effect of angiotensin II blockade on a new congenic model of hypertension derived from transgenic Ren-2 rats.
    Jessup JA; Gallagher PE; Averill DB; Brosnihan KB; Tallant EA; Chappell MC; Ferrario CM
    Am J Physiol Heart Circ Physiol; 2006 Nov; 291(5):H2166-72. PubMed ID: 16766648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of renin-angiotensin system blockade on renal angiotensin-(1-7) forming enzymes and receptors.
    Ferrario CM; Jessup J; Gallagher PE; Averill DB; Brosnihan KB; Ann Tallant E; Smith RD; Chappell MC
    Kidney Int; 2005 Nov; 68(5):2189-96. PubMed ID: 16221218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2.
    Ferrario CM; Jessup J; Chappell MC; Averill DB; Brosnihan KB; Tallant EA; Diz DI; Gallagher PE
    Circulation; 2005 May; 111(20):2605-10. PubMed ID: 15897343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential response of angiotensin peptides in the urine of hypertensive animals.
    Yamada K; Iyer SN; Chappell MC; Brosnihan KB; Fukuhara M; Ferrario CM
    Regul Pept; 1999 Mar; 80(1-2):57-66. PubMed ID: 10235635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary role of angiotensin-converting enzyme-2 in cardiac production of angiotensin-(1-7) in transgenic Ren-2 hypertensive rats.
    Trask AJ; Averill DB; Ganten D; Chappell MC; Ferrario CM
    Am J Physiol Heart Circ Physiol; 2007 Jun; 292(6):H3019-24. PubMed ID: 17308000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predominance of AT(1) blockade over mas-mediated angiotensin-(1-7) mechanisms in the regulation of blood pressure and renin-angiotensin system in mRen2.Lewis rats.
    Varagic J; Ahmad S; VonCannon JL; Moniwa N; Brosnihan KB; Wysocki J; Batlle D; Ferrario CM
    Am J Hypertens; 2013 May; 26(5):583-90. PubMed ID: 23459599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual ACE-inhibition and AT1 receptor antagonism improves ventricular lusitropy without affecting cardiac fibrosis in the congenic mRen2.Lewis rat.
    Jessup JA; Westwood BM; Chappell MC; Groban L
    Ther Adv Cardiovasc Dis; 2009 Aug; 3(4):245-57. PubMed ID: 19531557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential expression of nuclear AT1 receptors and angiotensin II within the kidney of the male congenic mRen2. Lewis rat.
    Pendergrass KD; Averill DB; Ferrario CM; Diz DI; Chappell MC
    Am J Physiol Renal Physiol; 2006 Jun; 290(6):F1497-506. PubMed ID: 16403834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential regulation of renal angiotensin-converting enzyme (ACE) and ACE2 during ACE inhibition and dietary sodium restriction in healthy rats.
    Hamming I; van Goor H; Turner AJ; Rushworth CA; Michaud AA; Corvol P; Navis G
    Exp Physiol; 2008 May; 93(5):631-8. PubMed ID: 18192334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Converting enzyme determines plasma clearance of angiotensin-(1-7).
    Yamada K; Iyer SN; Chappell MC; Ganten D; Ferrario CM
    Hypertension; 1998 Sep; 32(3):496-502. PubMed ID: 9740616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pouch tissue and angiotensin peptide generation.
    Katwa LC; Sun Y; Campbell SE; Tyagi SC; Dhalla AK; Kandala JC; Weber KT
    J Mol Cell Cardiol; 1998 Jul; 30(7):1401-13. PubMed ID: 9710808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intrarenal alterations of the angiotensin-converting enzyme type 2/angiotensin 1-7 complex of the renin-angiotensin system do not alter the course of malignant hypertension in Cyp1a1-Ren-2 transgenic rats.
    Husková Z; Kopkan L; Červenková L; Doleželová Š; Vaňourková Z; Škaroupková P; Nishiyama A; Kompanowska-Jezierska E; Sadowski J; Kramer HJ; Červenka L
    Clin Exp Pharmacol Physiol; 2016 Apr; 43(4):438-49. PubMed ID: 26833491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Upregulation of angiotensin-converting enzyme 2 after myocardial infarction by blockade of angiotensin II receptors.
    Ishiyama Y; Gallagher PE; Averill DB; Tallant EA; Brosnihan KB; Ferrario CM
    Hypertension; 2004 May; 43(5):970-6. PubMed ID: 15007027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Divergent pathways for the angiotensin-(1-12) metabolism in the rat circulation and kidney.
    Westwood BM; Chappell MC
    Peptides; 2012 Jun; 35(2):190-5. PubMed ID: 22490446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined suppression of the intrarenal and circulating vasoconstrictor renin-ACE-ANG II axis and augmentation of the vasodilator ACE2-ANG 1-7-Mas axis attenuates the systemic hypertension in Ren-2 transgenic rats exposed to chronic hypoxia.
    Červenka L; Bíbová J; Husková Z; Vaňourková Z; Kramer HJ; Herget J; Jíchová Š; Sadowski J; Hampl V
    Physiol Res; 2015; 64(1):11-24. PubMed ID: 25194129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sex differences in circulating and renal angiotensins of hypertensive mRen(2). Lewis but not normotensive Lewis rats.
    Pendergrass KD; Pirro NT; Westwood BM; Ferrario CM; Brosnihan KB; Chappell MC
    Am J Physiol Heart Circ Physiol; 2008 Jul; 295(1):H10-20. PubMed ID: 18456730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential regulation of circulating and renal ACE2 and ACE in hypertensive mRen2.Lewis rats with early-onset diabetes.
    Yamaleyeva LM; Gilliam-Davis S; Almeida I; Brosnihan KB; Lindsey SH; Chappell MC
    Am J Physiol Renal Physiol; 2012 Jun; 302(11):F1374-84. PubMed ID: 22378820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma and tissue concentrations of proangiotensin-12 in rats treated with inhibitors of the renin-angiotensin system.
    Nagata S; Kato J; Kuwasako K; Asami M; Kitamura K
    Hypertens Res; 2012 Feb; 35(2):234-8. PubMed ID: 21993212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Olmesartan is an angiotensin II receptor blocker with an inhibitory effect on angiotensin-converting enzyme.
    Agata J; Ura N; Yoshida H; Shinshi Y; Sasaki H; Hyakkoku M; Taniguchi S; Shimamoto K
    Hypertens Res; 2006 Nov; 29(11):865-74. PubMed ID: 17345786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence that prostaglandins mediate the antihypertensive actions of angiotensin-(1-7) during chronic blockade of the renin-angiotensin system.
    Iyer SN; Yamada K; Diz DI; Ferrario CM; Chappell MC
    J Cardiovasc Pharmacol; 2000 Jul; 36(1):109-17. PubMed ID: 10892668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.